ASP-9276

N/A

Report date: 2023/02/19 20:07:48

Base Information

Drug NameASP-9276
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsCandidiasisAspergillosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsCandidiasisAspergillosis

Other Information

ATC CodeN/A
Related LinksN/A